“…Furthermore, 5-HT 1A -and 5-HT 2A -receptors localized in the brain structures have been found to be implicated in neuroimmunomodulation [17,23,[77][78][79]. Application of a highly selective agonist of 5-HT 1A -receptors (+)-8-hydroxy-2-(di-N-propyl-amino) tetralin (8-OH-DPAT), named by some authors a "gold standard" for studying the functional activity of 5-HT 1A -receptors, at a dose activating central postsynaptic 5-HT 1A -receptors [69,80,81], led to a decrease in the number of spleen IgM-AFC in mice of different strains and in Wistar rats [78] immunized with SRBC (Table 2).…”